Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

P3 Health Partners (PIII) Equity Average (2020 - 2025)

P3 Health Partners (PIII) has disclosed Equity Average for 6 consecutive years, with $53.9 million as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Equity Average fell 65.64% year-over-year to $53.9 million, compared with a TTM value of $53.9 million through Jun 2025, down 65.64%, and an annual FY2022 reading of -$133.5 million, changed N/A over the prior year.
  • Equity Average was $53.9 million for Q2 2025 at P3 Health Partners, down from $69.6 million in the prior quarter.
  • Across five years, Equity Average topped out at $185.8 million in Q2 2022 and bottomed at -$244.0 million in Q4 2021.
  • Average Equity Average over 5 years is -$2.2 million, with a median of $25.9 million recorded in 2023.
  • The sharpest move saw Equity Average plummeted 137.37% in 2023, then surged 10456.61% in 2024.
  • Year by year, Equity Average stood at -$244.0 million in 2021, then surged by 117.2% to $42.0 million in 2022, then crashed by 38.31% to $25.9 million in 2023, then surged by 505.36% to $156.7 million in 2024, then tumbled by 65.64% to $53.9 million in 2025.
  • Business Quant data shows Equity Average for PIII at $53.9 million in Q2 2025, $69.6 million in Q1 2025, and $156.7 million in Q2 2024.